– Positive TNG462 clinical activity across multiple tumor types in the phase 1/2 clinical trial, program relocating into full development…
Read More
Paris-based FemTech app Solence raises €1.6 million to address PCOS with AI-driven digital therapeutics
French startup Solence, an app that supports women suffering from Polycystic Ovary Syndrome (PCOS), has raised €1.6 million in Seed…
Read MoreLyndra Therapeutics Announces Strategic Clinical Research and Commercial Manufacturing Services Collaboration with Thermo Fisher Scientific for Long-Acting Oral Therapies
Leveraging its Accelerator™ Drug Development, 360° CDMO and CMO solutions, Thermo Fisher will provide clinical research services for Lyndra’s phase…
Read MoreNimbus Therapeutics Announces Clinical Progress in Oncology Therapeutic Pipeline and Provides Business Updates
— Completion of IND submission for NDI-219216, a non-covalent WRN inhibitor for treatment of MSI-H tumors, with plans to initiate…
Read MoreTenpoint Therapeutics Ltd. and Visus Therapeutics, Inc. Join Forces, Building the Next Era of Best- and First-in-Class Ophthalmic Medicines
The company will file the NDA for BRIMOCHOL™ PF, a once-a-day eye drop for the treatment of presbyopia, with a…
Read More
